Uplistings & IPOs
Advertisement
Uplistings & IPOs
BioStem Technologies Graduates to Nasdaq as the Small-Cap Listing Window Stays Open
The Florida tissue-allograft maker began trading on the Nasdaq Capital Market on August 7, joining a 2026 new-listings calendar that is running ahead of last year's pace.
Uplistings & IPOs
First Phosphate Skips a Rung: ADR Uplisting Lands the LFP Developer on the Nasdaq Global Market
The Quebec-focused phosphate company moved its American Depositary Receipts from OTCQX to the Nasdaq Global Market on August 10 under the ticker PHOS — a cross-border listing route that raised no new capital and issued no new shares.